SPL 2.17% 9.4¢ starpharma holdings limited

Ann: DEP irinotecan clinical data presented at AACR meeting, page-17

  1. bid
    649 Posts.
    lightbulb Created with Sketch. 165
    Proof of concept first in entirety should see significant sp rise then negotiate deals from strength. To achieve maximum shareholder value is what I said. And that’s counter intuitive because?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.002(2.17%)
Mkt cap ! $38.35M
Open High Low Value Volume
9.3¢ 9.4¢ 9.3¢ $5.943K 63.90K

Buyers (Bids)

No. Vol. Price($)
1 6277 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 40000 1
View Market Depth
Last trade - 11.02am 19/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.